Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography - The LURIC study

International Journal of Cardiology

Volumn 174, Issue 1, 2014, Pages 96-105

  Scharnagl, Hubert ^a   Kleber, Marcus E ^b   Genser, Bernd ^b   Kickmaier, Sandra ^a   Renner, Wilfried ^a   Weihrauch, Gisela ^a   Grammer, Tanja ^b   Rossmann, Christine ^a   Winkelmann, Bernhard R ^c   Boehm, Bernhard O ^d,e,f   Sattler, Wolfgang ^a   März, Winfried ^a,b,g   Malle, Ernst ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ClinPhenomics Study Center   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g SYNLAB ACADEMY   (Germany)

Author keywords

Cardiovascular mortality; High density lipoprotein; Inflammation; Myeloperoxidase; Risk factor

Indexed keywords

APOLIPOPROTEIN A; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; SERUM AMYLOID A; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; PEROXIDASE;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; BLOOD; CARDIOVASCULAR DISEASE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MORTALITY; RISK;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RISK;

EID: 84901194381     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.168     Document Type: Article

References (52)

1. M.J. Davies, C.L. Hawkins, D.I. Pattison, and M.D. Rees Mammalian heme peroxidases: from molecular mechanisms to health implications Antioxid Redox Signal 10 2008 1199 1234
2. M.B. Hampton, A.J. Kettle, and C.C. Winterbourn Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing Blood 92 1998 3007 3017
3. Y.W. Yap, M. Whiteman, and N.S. Cheung Chlorinative stress: an under appreciated mediator of neurodegeneration? Cell Signal 19 2007 219 228
4. E. Malle, T. Buch, and H.J. Grone Myeloperoxidase in kidney disease Kidney Int 64 2003 1956 1967
5. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 2005 1102 1111
6. E.A. Podrez, H.M. Abu-Soud, and S.L. Hazen Myeloperoxidase-generated oxidants and atherosclerosis Free Radic Biol Med 28 2000 1717 1725
7. R. Zhang, M.L. Brennan, and X. Fu et al. Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142
8. W.H. Tang, M.L. Brennan, and K. Philip et al. Plasma myeloperoxidase levels in patients with chronic heart failure Am J Cardiol 98 2006 796 799
9. W.H. Tang, W. Tong, and R.W. Troughton et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure J Am Coll Cardiol 49 2007 2364 2370
10. S. Baldus, C. Heeschen, and T. Meinertz et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440 1445
11. G. Ndrepepa, S. Braun, J. Mehilli, N. von Beckerath, A. Schomig, and A. Kastrati Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes Eur J Clin Invest 38 2008 90 96
12. M. Sawicki, G. Sypniewska, and M. Kozinski et al. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes Eur J Clin Invest 41 2011 667 671
13. E. Cavusoglu, C. Ruwende, and C. Eng et al. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome Am J Cardiol 99 2007 1364 1368
14. L.W. Castellani, J.J. Chang, X. Wang, A.J. Lusis, and W.F. Reynolds Transgenic mice express human MPO - 463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in - 463G males J Lipid Res 47 2006 1366 1377
15. J.P. Yang, W.B. Wang, and X.X. Yang et al. The MPO - 463G > a polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies PLoS One 8 2013 e65778
16. B.R. Winkelmann, W. Marz, and B.O. Boehm et al. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease Pharmacogenomics 2 2001 S1 S73
17. W.G. Austen, J.E. Edwards, and R.L. Frye et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association Circulation 51 1975 5 40
18. G.C. Friesinger, E.E. Page, and R.S. Ross Prognostic significance of coronary arteriography Trans Assoc Am Physicians 83 1970 78 92
19. A.S. Levey, and L.A. Stevens Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions Am J Kidney Dis 55 2010 622 627
20. G. Dolley, B. Lamarche, J.P. Despres, C. Bouchard, L. Perusse, and M.C. Vohl Myeloperoxidase gene sequence variations are associated with low-density-lipoprotein characteristics J Hum Genet 53 2008 439 446
21. M.C. Meuwese, E.S. Stroes, and S.L. Hazen et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population study J Am Coll Cardiol 50 2007 159 165
22. M.L. Brennan, M.S. Penn, and F. Van Lente et al. Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 2003 1595 1604
23. T.J. Mocatta, A.P. Pilbrow, and V.A. Cameron et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction J Am Coll Cardiol 49 2007 1993 2000
24. V. Rudolph, T. Keller, and A. Schulz et al. Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest pain Circ Cardiovasc Genet 5 2012 561 568
25. T. Naruko, A. Furukawa, and K. Yunoki et al. Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina Heart 96 2010 1716 1722
26. J.I. Borissoff, I.A. Joosen, and M.O. Versteylen et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state Arterioscler Thromb Vasc Biol 33 2013 2032 2040
27. D.A. Morrow, M.S. Sabatine, and M.L. Brennan et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J 29 2008 1096 1102
28. G. Ferrante, M. Nakano, and F. Prati et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study Circulation 122 2010 2505 2513
29. F.S. Apple, S.W. Smith, L.A. Pearce, K.M. Schulz, R. Ler, and M.M. Murakami Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations Clin Chem 57 2011 603 608
30. W.H. Tang, Y. Wu, S.J. Nicholls, and S.L. Hazen Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease Clin Chem 57 2011 33 39
31. A. Stefanescu, S. Braun, and G. Ndrepepa et al. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease Am Heart J 155 2008 356 360
32. C.L. Heslop, J.J. Frohlich, and J.S. Hill Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography J Am Coll Cardiol 55 2010 1102 1109
33. J.A. Vita, M.L. Brennan, and N. Gokce et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans Circulation 110 2004 1134 1139
34. J.P. Eiserich, S. Baldus, and M.L. Brennan et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase Science 296 2002 2391 2394
35. S. Baldus, T. Heitzer, and J.P. Eiserich et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion Free Radic Biol Med 37 2004 902 911
36. L. Kubala, G. Lu, S. Baldus, L. Berglund, and J.P. Eiserich Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease Clin Chim Acta 394 2008 59 62
37. S.J. Nicholls, W.H. Tang, and D. Brennan et al. Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain Clin Chem 57 2011 1762 1770
38. T. Zhou, S.H. Zhou, S.S. Qi, X.Q. Shen, G.F. Zeng, and H.N. Zhou The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome Clin Chim Acta 368 2006 168 172
39. A.P. Kumar, and W.F. Reynolds Statins downregulate myeloperoxidase gene expression in macrophages Biochem Biophys Res Commun 331 2005 442 451
40. A. Hoy, D. Tregouet, and B. Leininger-Muller et al. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms Eur J Hum Genet 9 2001 780 786
41. B. Nikpoor, G. Turecki, C. Fournier, P. Theroux, and G.A. Rouleau A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians Am Heart J 142 2001 336 339
42. V. Rudolph, T.K. Rudolph, and L. Kubala et al. A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function Free Radic Biol Med 47 2009 1584 1590
43. R.V. Wainstein, M.V. Wainstein, and J.P. Ribeiro et al. Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease Clin Biochem 43 2010 57 62
44. R. Pecoits-Filho, P. Stenvinkel, and A. Marchlewska et al. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients Kidney Int Suppl 2003 S172 S176
45. F.W. Asselbergs, W.F. Reynolds, J.W. Cohen-Tervaert, G.A. Jessurun, and R.A. Tio Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease Am J Med 116 2004 429 430
46. C.W. Hamm, J.P. Bassand, and S. Agewall et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
47. P.G. Steg, S.K. James, and D. Atar et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
48. E.M. Antman, M. Cohen, and P.J. Bernink et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842
49. K.A. Fox, O.H. Dabbous, and R.J. Goldberg et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 333 2006 1091
50. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
51. J. Perk, G. De Backer, and H. Gohlke et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur Heart J 33 2012 1635 1701
52. E.M. Tuzcu, S.R. Kapadia, and E. Tutar et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound Circulation 103 2001 2705 2710